Series B funding from MedVenture Partners and DBJ Capital
- Author: admin_epmed
- Category: NEWS
We have raised Series B funding from MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., and DBJ Capital Co., Ltd.
We will continue to develop intravascular EEG measurement devices.
Related posts
E.P. Medical website launched
In November 2021, the E.P. Medical website was launched.
- Category: NEWS
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our Endovascular EEG device (EP-01).
We are pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for our…
- Category: NEWS
Investment in E.P. Medical Inc.
MPI-2 Investment Limited Partnership, managed and operated by MedVenture Partners Co., Ltd., has underwritten a Series A1 investment in E.P.…
- Category: NEWS
Regarding our company name change
As of December 13, 2023, our company name has changed from E.P.Medical Inc. to Epsilon Medical Inc. We appreciate your…
- Category: NEWS